Serina Therapeutics, Inc. (SER) Operating cash flow 2017–2025
Serina Therapeutics, Inc. (SER) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$18.0MFY2025 · since FY2017: -$6.3M → -$18.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.0M | -4.8% |
| FY2024 | -$17.1M | -592.1% |
| FY2023 | -$2.5M | +58.3% |
| FY2022 | -$5.9M | +24.4% |
| FY2021 | -$7.9M | -0.5% |
| FY2020 | -$7.8M | +23.1% |
| FY2019 | -$10.2M | -27.1% |
| FY2018 | -$8.0M | -27.2% |
| FY2017 | -$6.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice